Published in Biomed Res Int on August 08, 2016
Functional bowel disorders. Gastroenterology (2006) 20.72
Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr (1985) 10.24
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2013) 8.37
Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02
Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther (2013) 3.89
The Use of Mobile Devices in Aiding Dietary Assessment and Evaluation. IEEE J Sel Top Signal Process (2010) 3.64
Peripheral mechanisms in irritable bowel syndrome. N Engl J Med (2012) 3.40
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology (2002) 3.08
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.87
Irritable bowel syndrome: a clinical review. JAMA (2015) 2.26
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22
Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol (2010) 2.02
Use and abuse of hydrogen breath tests. Gut (2006) 1.97
Abnormal colonic fermentation in irritable bowel syndrome. Lancet (1998) 1.91
Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc (2006) 1.77
Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut (1986) 1.74
Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol (2007) 1.60
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.54
Breath hydrogen in hyposucrasia. Lancet (1976) 1.52
Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol (2011) 1.46
Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis (2009) 1.45
Glucose uptake and production during the oral glucose tolerance test. Diabetes (1968) 1.38
Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology (2014) 1.22
13C-breath tests: current state of the art and future directions. Dig Liver Dis (2007) 1.21
Lactose and milk intolerance: clinical implications. N Engl J Med (1975) 1.21
Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J (2000) 1.18
Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil (2006) 1.09
[13C]bicarbonate kinetics in humans: intra- vs. interindividual variations. Am J Physiol (1983) 1.07
Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol (1993) 1.06
Intestinal sucrase deficiency presenting as sucrose intolerance in adult life. Br Med J (1965) 1.02
13C-breath tests for sucrose digestion in congenital sucrase isomaltase-deficient and sacrosidase-supplemented patients. J Pediatr Gastroenterol Nutr (2009) 1.01
Stable isotopes: origins and safety. J Clin Pharmacol (1986) 1.00
Chemotherapy induced diarrhea. J Oncol Pharm Pract (2007) 0.97
Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment. Clin Nutr (2006) 0.96
Fructose malabsorption and intolerance: effects of fructose with and without simultaneous glucose ingestion. Crit Rev Food Sci Nutr (2011) 0.96
Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care. Am J Gastroenterol (2013) 0.95
The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms. Dig Dis Sci (2006) 0.92
Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep (2013) 0.92
The use of stable isotope techniques for nutritional and metabolic research in paediatrics. Early Hum Dev (1998) 0.91
Frequency of sucrase deficiency in mucosal biopsies. J Pediatr Gastroenterol Nutr (2012) 0.90
Disaccharidase activities in dyspeptic children: biochemical and molecular investigations of maltase-glucoamylase activity. J Pediatr Gastroenterol Nutr (2002) 0.89
Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'? Nat Rev Gastroenterol Hepatol (2014) 0.89
Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonist. Proc Natl Acad Sci U S A (2015) 0.86
Four mutations in the SI gene are responsible for the majority of clinical symptoms of CSID. J Pediatr Gastroenterol Nutr (2012) 0.85
Normalizing results of 13C-urea breath testing for CO2 production rates in children. J Pediatr Gastroenterol Nutr (1999) 0.84
Breath tests and irritable bowel syndrome. World J Gastroenterol (2014) 0.84
Fructose transporters GLUT5 and GLUT2 expression in adult patients with fructose intolerance. United European Gastroenterol J (2014) 0.84
13CO2 breath test to measure the hydrolysis of various starch formulations in healthy subjects. Gut (1990) 0.84
Clinical impact of identifying lactose maldigestion or fructose malabsorption in irritable bowel syndrome or other conditions. South Med J (2009) 0.83
Breath tests: concepts, applications and limitations. Eur J Pediatr (1997) 0.83
Disaccharide digestion and maldigestion. Scand J Gastroenterol Suppl (1996) 0.83
Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. J Gastroenterol (2015) 0.83
Improved infrared spectrophotometer for point-of-care patient 13C-urea breath testing in the primary care setting. Clin Biochem (2005) 0.82
Carbohydrate malabsorption in clinical routine: a prospective observational study. Hepatogastroenterology (2006) 0.82
Use of 13C-labeled glucose for estimating glucose oxidation: some design considerations. J Appl Physiol (1985) (1987) 0.81
Intraluminal and mucosal starch digestion in congenital deficiency of intestinal sucrase and isomaltase activities. Pediatr Res (1972) 0.81
Proof-of-concept study on the suitability of 13C-urea as a marker substance for assessment of in vivo behaviour of oral colon-targeted dosage forms. Br J Pharmacol (2009) 0.81
Dietary Renaissance in IBS: Has Food Replaced Medications as a Primary Treatment Strategy? Curr Treat Options Gastroenterol (2014) 0.81
Gas bubble formation in the cytoplasm of a fermenting yeast. FEMS Yeast Res (2012) 0.80
Congenital sucrase-isomaltase deficiency: heterogeneity of inheritance, trafficking, and function of an intestinal enzyme complex. J Pediatr Gastroenterol Nutr (2012) 0.80
Using the noninvasive (13)C-sucrose breath test to measure intestinal sucrase activity in swine. Comp Med (2012) 0.79
Optimization of the non-invasive 13C-sucrose breath test in a rat model of methotrexate-induced mucositis. Cancer Chemother Pharmacol (2009) 0.79
Disaccharidase Deficiencies in Children With Chronic Abdominal Pain. JPEN J Parenter Enteral Nutr (2016) 0.78
Recent advances in the diagnosis of irritable bowel syndrome. Expert Rev Gastroenterol Hepatol (2015) 0.77
13C-sucrose breath test: novel use of a noninvasive biomarker of environmental gut health. Pediatrics (2009) 0.77
Molecular aspects of disaccharidase deficiencies. Baillieres Clin Gastroenterol (1990) 0.76
Examination of small bowel enzymes in chronic diarrhea. J Gastroenterol Hepatol (2003) 0.76
A double-blind clinical trial with a digestive enzyme product. Br J Clin Pract (1971) 0.76